Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study looking at the causes of Hodgkin lymphoma
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
In this study researchers want to look at the possible causes of Hodgkin lymphoma (Hodgkin’s disease). The study is for children as well as adults. We use the term ‘you’ in this summary, but if you are a parent, we are referring to your child.
We don’t know exactly what causes Hodgkin lymphoma. The researchers want to look at tissue and blood samples taken from people with Hodgkin lymphoma to try and find out more. They particularly want to learn more about a virus called Epstein Barr, which we know can be linked to Hodgkin lymphoma.
Researchers will use the samples to look at your
You will not get any direct benefit from taking part in this trial, nor will it affect any treatment you have.
The aim of this study is to
- Find out more about what causes Hodgkin lymphoma
- Find out why treatment for Hodgkin lymphoma works better for some people than others
Who can enter
You may be able to enter this trial if you have been diagnosed with Hodgkin lymphoma.
This study will recruit people who have recently been diagnosed with Hodgkin lymphoma. You will have had a
You will have blood samples for the study taken before you start treatment and when you see your cancer specialist. Only adults in the trial will have blood samples taken. The researchers will use these to look at your DNA and any viruses you may have had.
There are no extra hospital visits for this study. The researchers will use the tissue sample (biopsy) you gave when you were diagnosed. You can give blood samples at your routine visit to hospital to see your cancer specialist.
As there are no treatments involved in this trial, the only side effect you may have is a small bruise where you gave the blood sample.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ruth Jarrett
National Institute for Health Research Cancer Research Network (NCRN)
University of Glasgow